NCT06070012 2026-02-27Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal MelanomaUniversity of PittsburghPhase 2 Recruiting44 enrolled
NCT06942442 2025-12-26A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell SarcomaSarcoma Alliance for Research through CollaborationPhase 2 Recruiting47 enrolled